1. Munch G, Neverve J, Matsunari I, Schroter G, Schwaiger M (1997) Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease. J Nucl Med 38(3):428–432
2. Beller GA, Watson DD (1991) Physiological basis of myocardial perfusion imaging with the technetium 99m agents. Semin Nucl Med 21(3):173–181
3. Wackers FJ, Berman DS, Maddahi J et al (1989) Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 30(3):301–311
4. Piepsz A, Hahn K, Roca I et al (1990) A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine. Eur J Nucl Med 17(3–4):127–129
5. Hesse B, Tagil K, Cuocolo A et al (2005) EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 32(7):855–897